Phil Cunnah

Rodon Biologics as a biotech CRDMO have 20 years of activity engineering, producing, analysing, characterising and delivering recombinant protein as well as small molecules from engineered microorganisms delivering processes, data and products for discovery, early stage and preclinical research up to manufacture. Over the years Rodon have worked with clients from small start-ups through to larger pharma and biotech on an international level supporting projects from early research and discovery, through development and manufacture Rodon’s approach is customer centric establishing a close and collaborative working relationship contributing to the success of our customer’s projects as we believe their success is our success.